Successful control of outbreak caused by clonally related extensively-resistant Acinetobacter baumannii in an intensive care unit

Yıl 2017, Cilt: 07 Sayı: 01, 1 - 6, 01.03.2017

Bushra Sultan

https://doi.org/10.5799/jmid.328849

Öz

Objective: Worldwide drug resistance in Acinetobacter baumannii is on the rise. We report outbreak of extensivelyresistant
(XDR) A. baumannii in a medical intensive care unit (MICU) at a tertiary care referral hospital in Pakistan.
During subsequent survey, 10 extensively-resistant A. baumannii were isolated from 8 environmental samples and
hands of 2 healthcare workers (HCWs).
Methods: In January 2013, XDR A. baumannii (Ab1, Ab2, and Ab3) were isolated from tracheal aspirate, blood and
sputum of three patients with ventilator associated pneumonia. The isolates were resistant to piperacillin, ampicillinsulbactam,
piperacillin-tazobactam, ticarcillin-clavulanic acid, ceftazidime, cefipime, ceftriaxone, imipenem,
meropenem, gentamicin, amikacin, doxycycline, minocycline, ciprofloxacin and trimethoprim-sulphamethoxazole..
Pulsed Field Gel Electrophoresis (PFGE) revealed that isolates from HCWs were similar to the genotype initially
isolated from patients’ samples.
Results: Control of the outbreak was attained with requisite infection control practices and fumigation of the Medical
ICU unit. From February 2013 to April 2013 there were no new cases of extensively-resistant isolates in medical ICU.
However, two more cases with similar antibiogram MICs and genotype of extensively-resistant isolates emerged in
June 2013 from the same MICU.
Conclusion: Stringent infection control measures were implemented this time with continuous monitoring and regular
surveillance. Follow up for the next two years has been successful as no clustering of XDR A. baumannii were
detected from medical and surgical ICUs. J Microbiol Infect Dis 2017; 7(1): 1-6  

Anahtar Kelimeler

Hospital Infection Control, health care workers, surveillance

Kaynakça

• 1. Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 2008; 21: 538-582.
• 2. Durante-Mangoni E, Zarrilli R. Global spread of multi-drug-resistant Acinetobacter baumannii: molecular epidemiology and management of antimicrobial resistance. Future Micro-biol 2011; 6(4): 407-422.
• 3. Kramer A, Schwebke I, Kampf G. How long do nosocomial pathogens persist on inanimate surfaces? A systematic review. BMC Infect Dis 2006; 6:130.
• 4. Aygun G, Demirkiran O, Utku T, et al. Environmental contamination during a carbapenem-resistant Acinetobacter bau-mannii outbreak in an intensive care unit. J Hosp Infect 2002; 52:259-262.
• 5. Levin AS, Gobara S, Mendes CM, Cursino MR, Sinto S. Environmental contamination by multidrug-resistant Aci-netobacter baumannii in an intensive care unit. Infect Con-trol Hosp Epidemiol 2001; 22:717-720.
• 6. Lee NY, Lee HC, Ko NY, et al. Clinical and economic impact of multidrug resistance in nosocomial Acinetobacter baumannii bacteremia. Infect Control Hosp Epidemiol 2007; 28: 713-719.
• 7. Kwon KT, Oh WS, Song JH, et al. Impact of imipenem resistance on mortality in patients with Acinetobacter bacteraemia. J Antimicrob Chemother 2007; 59:525-530.
• 8. Seifert H, Dolzani L, Bressan R. Standardization and interlaboratory reproducibility assessment of Pulsed-Field Gel Electrophoresis generated fingerprints of Acinetobacter baumannii. J Clin Microbiol 2005; 43(9): 4328–4335.
• 9. Lopes BS, Al-Hassan L, Amyes SGB. ISAba825 controls the expression of the chromosomal b/aOXA-51-like and the plasmid borne blaOXA-58 gene in clinical isolates of Aci-netobacter baumannii isolated from the USA. Clin Microbiol Infect 2012; 18(11):E446-451.
• 10. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing approved standard 24th ed. Wayne, PA: CLSI: 2014 [DocumentM100-S24].
• 11. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, Swaminathan B. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel elec-trophoresis: criteria for bacterial strain typing. J Clin Micro-biol 1995; 33:2233–2239.
• 12. Markogiannakis A, Fildisis G, Tsiplakou S, et al. Cross-transmission of multidrug-resistant Acinetobacter baumannii clonal strains causing episodes of sepsis in a trauma intensive care unit. Infect Control Hosp Epidemiol 2008; 29:410-417.
• 13. Wybo I, Blommaert L, De Beer T, et al. Outbreak of multidrug-resistant Acinetobacter baumannii in a Belgian university hospital after transfer of patients from Greece. J Hosp Infect 2007; 67:374- 380.
• 14. El Shafie SS, Alishaq M, Leni Garcia M. Investigation of an outbreak of multidrug-resistant Acinetobacter baumannii in trauma intensive care unit. J Hosp Infect 2004; 56:101-105.
• 15. Playford EG, Craig JC, Iredell JR. Carbapenemresistant Acinetobacter baumannii in intensive care unit patients: risk factors for acquisition, infection and their consequences. J Hosp Infect 2007; 65:204-211.
• 16. Zanetti G, Blanc DS, Federli I, et al. Importation of Acinetobacter baumannii into a burn unit: a recurrent outbreak of infection associated with widespread environmental contamination. Infect Control Hosp Epidemiol 2007; 28:723–725.
• 17. D'Agata EM, Thayer V, Schaffner W. An outbreak of Aci-netobacter baumannii: the importance of cross-transmission. Infect Control Hosp Epidemiol 2000; 21:588–591.
• 18. Zarrilli R, Pournaras S, Giannouli M, Tsakris A. Global evo-lution of multidrug-resistant Acinetobacter baumannii clonal lineages. Int J Antimicrob Agents 2013; 41(1): 11–19.